The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen
Abstract
In an effort to identify tumor-specific antigens recognized by CD4 + T cells, an approach was developed that allows the screening of an invariant chain–complementary DNA fusion library in a genetically engineered cell line expressing the essential components of the major histocompatibility complex (MHC) class II processing and presentation pathway. This led to the identification of a mutated form of human CDC27, which gave rise to an HLA-DR4–restricted melanoma antigen. A mutated form of triosephosphate isomerase, isolated by a biochemical method, was also identified as an HLA-DR1–restricted antigen. Thus, this approach may be generally applicable to the identification of antigens recognized by CD4 + T cells, which could aid the development of strategies for the treatment of patients with cancer, autoimmune diseases, or infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., & Nagata, S. (1998) · Nature · doi:10.1038/34112 · Cited by 3,189
A role for sunlight in skin-cancer – UV-induced p53 mutations in squamous-cell carcinoma
Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., & Pontén, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10124 · Cited by 1,959
Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., & Riddell, S. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331603 · Cited by 1,771
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., & Miyamoto, S. (1995) · Genes & Development · doi:10.1101/gad.9.22.2723 · Cited by 1,724
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Germain, R. N. (1994) · Cell · doi:10.1016/0092-8674(94)90336-0 · Cited by 1,434
The ubiquitin-proteasome pathway: on protein death and cell life
Ciechanover, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7151 · Cited by 1,426
Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Protein kinase recognition sequence motifs
Kemp, B. E., & Pearson, R. B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90073-k · Cited by 995
Organ-Specific Disease Provoked by Systemic Autoimmunity
Kouskoff, V., Korganow, A.-S., Duchatelle, V., Degott, C., Benoist, C., & Mathis, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81989-3 · Cited by 892
Assembly, Transport, and Function of MHC Class II Molecules
Cresswell, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.259 · Cited by 807
HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading
Denzin, L. K., & Cresswell, P. (1995) · Cell · doi:10.1016/0092-8674(95)90061-6 · Cited by 686
The role of CD4+ T cell responses in antitumor immunity
Pardoll, D. M., & Topalian, S. L. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80228-8 · Cited by 672
Self-citationSeveral Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
Southwood, S., Sidney, J., Kondo, A., del Guercio, M.-F., Appella, E., Hoffman, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., & Sette, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3363 · Cited by 665
The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses
Kalams, S. A., & Walker, B. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2199 · Cited by 660
T Helper Cell Subsets in Insulin-Dependent Diabetes
Katz, J. D., Benoist, C., & Mathis, D. (1995) · Science · doi:10.1126/science.7761837 · Cited by 593
Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1185 · Cited by 550
Self-citationInvariant Chain Structure and MHC Class II Function
Cresswell, P. (1996) · Cell · doi:10.1016/s0092-8674(00)81025-9 · Cited by 380
Tugendreich, S., Tomkiel, J., Earnshaw, W., & Hieter, P. (1995) · Cell · doi:10.1016/0092-8674(95)90336-4 · Cited by 368
Perfection in enzyme catalysis: the energetics of triosephosphate isomerase
Knowles, J. R., & Albery, W. J. (1977) · Accounts of Chemical Research · doi:10.1021/ar50112a001 · Cited by 364
Topalian, S. L., Rivoltini, L., Mancini, M., Markus, N. R., Robbins, P. F., Kawakami, Y., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9461 · Cited by 286
Self-citationWang, R. F., Robbins, P. F., Kawakami, Y., Kang, X. Q., & Rosenberg, S. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.799 · Cited by 270
Self-citationMelanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
Topalian, S. L., Gonzales, M. I., Parkhurst, M., Li, Y. F., Southwood, S., Sette, A., Rosenberg, S. A., & Robbins, P. F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.1965 · Cited by 257
Self-citationPrinciples for Adoptive T Cell Therapy of Human Viral Diseases
Riddell, S. R. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.545 · Cited by 248
CD4+ T-cell subsets in autoimmunity
O'Garra, A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80192-6 · Cited by 243
A unique tumor antigen produced by a single amino acid substitution
Monach, P. A., Meredith, S. C., T.Siegel, C., & Schreiber, H. (1995) · Immunity · doi:10.1016/1074-7613(95)90078-0 · Cited by 241
Clauser, K. R., Hall, S. C., Smith, D. M., Webb, J. W., Andrews, L. E., Tran, H. M., Epstein, L. B., & Burlingame, A. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.5072 · Cited by 205
Wang, R.-F., Johnston, S. L., Zeng, G., Topalian, S. L., Schwartzentruber, D. J., & Rosenberg, S. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3596 · Cited by 204
Self-citationBiochemical Identification of a Mutated Human Melanoma Antigen Recognized by CD4+ T Cells
Pieper, R., Christian, R. E., Gonzales, M. I., Nishimura, M. I., Gupta, G. P., Settlage, R. E., Shabanowitz, J., Rosenberg, S. A., Hunt, D. F., & Topalian, S. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.757 · Cited by 190
Self-citationTumor immunotherapy: the tumor cell as an antigen-presenting cell
Ostrand‐Rosenberg, S. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90075-2 · Cited by 130
Positive Selection of T Cells Induced by Viral Delivery of Neopeptides to the Thymus
Nakano, N., Rooke, R., Benoist, C. O., et al. (1997) · Science · doi:10.1126/science.275.5300.678 · Cited by 108
Halder, T. M., Pawelec, G., Kirkin, A. F., Zeuthen, J., Meyer, H. E., Kun, L., & Kalbacher, H. (1997) · PubMed · Cited by 84
Tugendreich, S., Boguski, M. S., Seldin, M. F., & Hieter, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10031 · Cited by 54
A two‐dimensional gel database of human colon carcinoma proteins
Ji, H., Reid, G. E., Moritz, R. L., et al. (1997) · Electrophoresis · doi:10.1002/elps.1150180344 · Cited by 53
Chen, P., Ueng, Y.-C., Durfee, T. J., Chen, K.-C., Yang-Feng, T. L., & Lee, W. (1995) · PubMed · Cited by 27
Cited by
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Van Allen, E. M., Miao, D., Schilling, B., Shukla, S. A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Geukes Foppen, M. H., Goldinger, S. M., et al. (2015) · Science · doi:10.1126/science.aad0095 · Cited by 2,839
Progress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,325
Self-citationMutant MHC class II epitopes drive therapeutic immune responses to cancer
Kreiter, S., Vormehr, M., van de Roemer, N., Diken, M., Löwer, M., Diekmann, J., Boegel, S., Schrörs, B., Vascotto, F., Castle, J. C., et al. (2015) · Nature · doi:10.1038/nature14426 · Cited by 1,243
Dendritic cells as therapeutic vaccines against cancer
Banchereau, J., & Palucka, A. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1592 · Cited by 1,204
Exploring treatment options in cancer: tumor treatment strategies
Liu, B., Zhou, H., Tan, L., Siu, K. T. H., & Guan, X.-Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01856-7 · Cited by 1,201
Metadata
- Authors
- Wang, R.-F., Wang, X., Atwood, A. C., Topalian, S. L., & Rosenberg, S. A.
- Venue
- Science
- Published
- 1999-05-21
- Volume
- 284
- Issue
- 5418
- Pages
- 1351-1354
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1966023886
- Cited by
- 300
- References
- 38
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.